Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202206584817951Phase 2Completed
Phase 2 trial of praziquantel in malaria and Falciparum malaria (PF) (2 arms). Primary endpoint: Proportion of participants with microscopically determined parasite clearance on day 7. Started Mar 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202206584817951.